Top View
- (12) Patent Application Publication (10) Pub. No.: US 2017/0042898A1 Berenson Et Al
- PRMT1 Inhibition Induces Differentiation of Colon Cancer Cells
- A61k9/00 (2006.01) A61k9/51 (2006.01)
- HDAC Inhibitors As Cognitive Enhancers in Fear, Anxiety and Trauma Therapy: Where Do We Stand?
- Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet
- In Relapsed and Refractory Hodgkin Lymphoma
- P53-Dependent and P53-Independent Anticancer Effects of Different Histone Deacetylase Inhibitors
- Phase 1/1B Pembrolizumab Plus Vorinostat in Advanced NSCLC
- Histone Deacetylase Inhibitors Impair the Host Immune Response Against Mycobacterium Tuberculosis Infection T
- Histone Deacetylase Inhibitors
- Hazardous Chemical Agents (Anti-Neoplastic, Carcinogens, Reproductive Hazards, Neurotoxic)
- HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
- Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy
- A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, In
- Entinostat for the Treatment of Breast Cancer Dario Trapani1, Angela Esposito1, Carmen Criscitiello1, Giulia Viale1, Luca Mazzar
- Specific Mtor Inhibitors in the Treatment of X-Linked Adrenoleukodystrophy
- W W W .Bio Visio N .Co M
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Polatuzumab Vedotin
- A Dissertation by A
- A View Into Upcoming Specialty & Traditional Drugs
- Non-Hydroxamate Zinc-Binding Groups As Warheads for Histone Deacetylases
- A Novel High-Content Immunofluorescence Assay As a Tool to Identify at the Single Cell Level Γ-Globin Inducing Compounds
- Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively
- The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence MARILITA M
- Chemical Genomics Reveals Histone Deacetylases Are Required for Core Regulatory Transcription
- The Critical Roles of Histone Deacetylase 3 in the Pathogenesis of Solid Organ Injury ✉ ✉ Li Ning1,2, Xiong Rui1,2, Wang Bo1 and Geng Qing1
- EKO Med-Info, März 2021
- Wo 2009/067543 A2
- A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer
- Strategies of Cancer Immunotherapy: Model of Triple Negative Breast Cancer
- 4780.Full-Text.Pdf
- Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High Dose Interleukin 2: a Multicenter, Single-Arm, Phase 1/2 Trial (NCI- CTEP#7870)
- Activity of Epigenetic Inhibitors Against Plasmodium Falciparum Asexual And
- Biomedicines
- Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms Maria Pinkerneil1, Michele J
- The Role of Cannabinoids and Their Receptors in Breast Cancer DISSERTATION Presented in Partial Fulfillment of the Requirements
- Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High Dose Interleukin 2: a Multicenter, Single-Arm, Phase 1/2 Trial (NCI- CTEP#7870)
- Role of Checkpoint Kinase 1 (Chk1) in the Mechanisms of Resistance to Histone Deacetylase Inhibitors
- RNF5 Regulation of RBBP4 Defines Acute Myeloid Leukemia Growth and Susceptibility to Histone Deacetylase Inhibitors
- MGMT-Activated DUB3 Stabilizes MCL1 and Drives Chemoresistance in Ovarian Cancer